Effect of Anti-IgE (Omalizumab) in chronic idiopathic urticaria (CIU) patients

被引：43

作者：

Gober, L. M. ^{[1
]}

Sterba, P. M. ^{[1
]}

Eckman, J. A. ^{[1
]}

Saini, S. S. ^{[1
]}

机构：

[1] Johns Hopkins Univ, Baltimore, MD 21218 USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2008年 / 121卷 / 02期

关键词：

D O I：

10.1016/j.jaci.2007.12.1121

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

566

引用

页码：S147 / S147

页数：1

共 50 条

[1] Omalizumab, an Anti-IgE mAb, Receives Approval for the Treatment of Chronic Idiopathic/Spontaneous Urticaria
Wu, Keith C. P.
Jabbar-Lopez, Zarif K.
[J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (01) : 13 - 15
[2] Effect of omalizumab in a patient with chronic idiopathic urticaria (CIU) and elevated ige receptor antibodies.
Spector, S. L.
Tan, R. A.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2007, 98 (01) : A23 - A23
[3] Chronic (Cold) Contact Urticaria Treated Successfully with Anti-IgE (Omalizumab)
Ozdemir, Oner
[J]. ASTIM ALLERJI IMMUNOLOJI, 2020, 18 (01): : 54 - 55
[4] Efficacy of omalizumab treatment for patients with chronic idiopathic urticaria (CIU)/chronic spontaneous urticaria (CSU) in Taiwan
Yan, Che-Wen
Cho, Yung-Tsu
Chu, Chia-Yu
[J]. DERMATOLOGICA SINICA, 2017, 35 (04) : 182 - 186
[5] C reactive protein (CRP) & IgG Anti-IgE/IgE receptor (FCεR1) antibodies in chronic idiopathic urticaria (CIU)
Kaviani, M
Warrington, RJ
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S123 - S123
[6] Anti-IgE for the Treatment of Chronic Urticaria
Wedi, Bettina
Traidl, Stephan
[J]. IMMUNOTARGETS AND THERAPY, 2021, 10 : 27 - 45
[7] Successful treatment of chronic idiopathic urticaria & Angioedema (CIU), with Xolair (omalizumab)
Shapiro, C. A.
Kapetanos, N. S.
Sarmiento, E.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S274 - S274
[8] EFFICACY OF OMALIZUMAB, AN ANTI-IGE RECOMBINANT, HUMANIZED, MONOCLONAL ANTIBODY, FOR THE TREATMENT OF SEVERE CHRONIC IDIOPATHIC URTICARIA PATIENTS NOT CONTROLLED ON ORAL ANTIHISTAMINES
Nsouli, S. M.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (05) : A117 - A117
[9] Successful treatment of four types of chronic urticaria with anti-IgE omalizumab in the same patient
Nettis, Eustachio
Di Leo, Elisabetta
Calogiuri, Gianfranco
Foti, Caterina
Macchia, Luigi
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 122 (03) : 336 - 337
[10] Omalizumab response in patients with chronic idiopathic urticaria: Insights from the XTEND-CIU study
Casale, Thomas B.
Win, Patrick H.
Bernstein, Jonathan A.
Rosen, Karin
Holden, Michael
Iqbal, Ahmar
Trzaskoma, Benjamin L.
Yang, Ming
Antonova, Evgeniya N.
Murphy, Thomas
Scarupa, Mark D.
Sofen, Howard
Kaplan, Allen
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (04) : 793 - 795

← 1 2 3 4 5 →